These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31730345)

  • 1. How Significant Are Unusual Protein-Ligand Interactions? Insights from Database Mining.
    Kuhn B; Gilberg E; Taylor R; Cole J; Korb O
    J Med Chem; 2019 Nov; 62(22):10441-10455. PubMed ID: 31730345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Halogens in Protein-Ligand Binding Mechanism: A Structural Perspective.
    Shinada NK; de Brevern AG; Schmidtke P
    J Med Chem; 2019 Nov; 62(21):9341-9356. PubMed ID: 31117513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Halogen-Hydrogen Bond Donor Interactions Dominate the Favorable Contribution of Halogens to Ligand-Protein Binding?
    Lin FY; MacKerell AD
    J Phys Chem B; 2017 Jul; 121(28):6813-6821. PubMed ID: 28657759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovering protein-ligand chalcogen bonding in the protein data bank using endocyclic sulfur-containing heterocycles as ligand search subsets.
    Mitchell MO
    J Mol Model; 2017 Sep; 23(10):287. PubMed ID: 28942498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design.
    Lu Y; Wang Y; Zhu W
    Phys Chem Chem Phys; 2010 May; 12(18):4543-51. PubMed ID: 20428531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong and weak hydrogen bonds in the protein-ligand interface.
    Panigrahi SK; Desiraju GR
    Proteins; 2007 Apr; 67(1):128-141. PubMed ID: 17206656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the potential of halogen bonding in molecular design: automated scaffold decoration using the new scoring function XBScore.
    Zimmermann MO; Lange A; Boeckler FM
    J Chem Inf Model; 2015 Mar; 55(3):687-99. PubMed ID: 25654403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halogen bonding for rational drug design and new drug discovery.
    Lu Y; Liu Y; Xu Z; Li H; Liu H; Zhu W
    Expert Opin Drug Discov; 2012 May; 7(5):375-83. PubMed ID: 22462734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A knowledge-based halogen bonding scoring function for predicting protein-ligand interactions.
    Liu Y; Xu Z; Yang Z; Chen K; Zhu W
    J Mol Model; 2013 Nov; 19(11):5015-30. PubMed ID: 24072554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halogenated ligands and their interactions with amino acids: implications for structure-activity and structure-toxicity relationships.
    Kortagere S; Ekins S; Welsh WJ
    J Mol Graph Model; 2008 Sep; 27(2):170-7. PubMed ID: 18524655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-X...H contacts in biomolecular systems: how they contribute to protein-ligand binding affinity.
    Lu Y; Wang Y; Xu Z; Yan X; Luo X; Jiang H; Zhu W
    J Phys Chem B; 2009 Sep; 113(37):12615-21. PubMed ID: 19708644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halogen-enriched fragment libraries as chemical probes for harnessing halogen bonding in fragment-based lead discovery.
    Zimmermann MO; Lange A; Wilcken R; Cieslik MB; Exner TE; Joerger AC; Koch P; Boeckler FM
    Future Med Chem; 2014 Apr; 6(6):617-39. PubMed ID: 24895892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement of Protein Binding-Site Waters Contributes to Favorable Halogen Bond Interactions.
    Wang Y; Fu Q; Zhou Y; Du Y; Huang N
    J Chem Inf Model; 2019 Jul; 59(7):3136-3143. PubMed ID: 31187992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition and display of steric, hydrophobic, and hydrogen-bonding properties of ligand binding sites in proteins using Lee and Richards accessible surface: validation of a high-resolution graphical tool for drug design.
    Bohacek RS; McMartin C
    J Med Chem; 1992 May; 35(10):1671-84. PubMed ID: 1588550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halogen bonding in halocarbon-protein complexes and computational tools for rational drug design.
    Costa PJ; Nunes R; Vila-Viçosa D
    Expert Opin Drug Discov; 2019 Aug; 14(8):805-820. PubMed ID: 31131651
    [No Abstract]   [Full Text] [Related]  

  • 16. Halogen interactions in protein-ligand complexes: implications of halogen bonding for rational drug design.
    Sirimulla S; Bailey JB; Vegesna R; Narayan M
    J Chem Inf Model; 2013 Nov; 53(11):2781-91. PubMed ID: 24134121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rediscovery of halogen bonds in protein-ligand complexes.
    Zhou P; Tian F; Zou J; Shang Z
    Mini Rev Med Chem; 2010 Apr; 10(4):309-14. PubMed ID: 20470246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Noncompetitive Protein-Ligand Interactions for Structural Optimization.
    Tosstorff A; Cole JC; Taylor R; Harris SF; Kuhn B
    J Chem Inf Model; 2020 Dec; 60(12):6595-6611. PubMed ID: 33085891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of the role of nitrile groups in protein-ligand interactions.
    Wang Y; Du Y; Huang N
    Future Med Chem; 2018 Dec; 10(23):2713-2728. PubMed ID: 30518255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLIFS: a knowledge-based structural database to navigate kinase-ligand interaction space.
    van Linden OP; Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    J Med Chem; 2014 Jan; 57(2):249-77. PubMed ID: 23941661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.